<DOC>
	<DOC>NCT01766752</DOC>
	<brief_summary>Objective: To investigate the performance (safety) of the GlucoTab system for glycaemic management in non-critically ill patients with type 2 diabetes at the general ward</brief_summary>
	<brief_title>Performance of a Tablet Based Workflow and Decision Support System With Incorporated Software Algorithm Used for Glycaemic Management</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus, Type 2</mesh_term>
	<criteria>Informed consent obtained after being advised of the nature of the study Male or female aged 18 90 years (both inclusive) Type 2 diabetes treated with diet, oral agents, noninsulin injected antidiabetic medicine, insulin therapy or any combination of the four Impaired renal function (serum creatinine â‰¥3.0mg/dL) Any disease or condition which the investigator or treating physician feels would interfere with the trial or the safety of the patient Pregnancy Any mental condition rendering the patient incapable of giving his consent Terminally ill patients Participation in a trial within 3 months prior to this trial Known or suspected allergy to insulin</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>January 2013</verification_date>
</DOC>